Distinct microRNA expression signatures are associated with melanoma subtypes and are regulated by HIF1A

Pigment Cell and Melanoma Research

Volumn 27, Issue 5, 2014, Pages 777-787

  Hwang, Hun Way ^a,b   Baxter, Laura L ^a   Loftus, Stacie K ^a   Cronin, Julia C ^a   Trivedi, Niraj S ^a   Borate, Bhavesh ^a   Pavan, William J ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Bnip3; HIF1; Hypoxia; Melanoma; MiRNA

Indexed keywords

BNIP3 PROTEIN, MOUSE; HIF1A PROTEIN, HUMAN; HIF1A PROTEIN, MOUSE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MEMBRANE PROTEIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; MICRORNA; MIRN210 MICRORNA, HUMAN; MIRN218 MICRORNA, HUMAN; MIRN224 MICRORNA, HUMAN; MIRN452 MICRORNA, HUMAN; MITF PROTEIN, HUMAN; MITF PROTEIN, MOUSE; MITOCHONDRIAL PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; CELL CYCLE; CLUSTER ANALYSIS; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME; HUMAN; MELANOMA; METABOLISM; MOUSE; PATHOLOGY; TUMOR CELL LINE; UPREGULATION;

ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MELANOMA; MEMBRANE PROTEINS; MICE; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MICRORNAS; MITOCHONDRIAL PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 84906809924     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12255     Document Type: Article

References (44)

1. Ameri, K., Hammond, E.M., Culmsee, C. et al. (2007). Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signalling pathway. Oncogene 26, 284-289.
2. Azad, M.B., and Gibson, S.B. (2010). Role of BNIP3 in proliferation and hypoxia-induced autophagy: implications for personalized cancer therapies. Ann. N. Y. Acad. Sci. 1210, 8-16.
3. Baek, D., Villén, J., Shin, C., Camargo, F.D., Gygi, S.P., and Bartel, D.P. (2008). The impact of microRNAs on protein output. Nature 455, 64-71.
4. Baskerville, S., and Bartel, D.P. (2005). Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11, 241-247.
5. Bell, R.E., Khaled, M., Netanely, D. et al. (2014). Transcription Factor/microRNA Axis Blocks Melanoma Invasion Program by miR-211 Targeting NUAK1. J. Invest. Dermatol. 134, 441-451.
6. Benita, Y., Kikuchi, H., Smith, A.D., Zhang, M.Q., Chung, D.C., and Xavier, R.J. (2009). An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res. 37, 4587-4602.
7. Bonazzi, V.F., Stark, M.S., and Hayward, N.K. (2012). MicroRNA regulation of melanoma progression. Melanoma Res. 22, 101-113.
8. Chan, S.Y., and Loscalzo, J. (2010). MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 9, 1072-1083.
9. Cheli, Y., Giuliano, S., Fenouille, N. et al. (2012). Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells. Oncogene 31, 2461-2470.
10. Day, C.-P., Carter, J., Bonomi, C., Esposito, D., Crise, B., Ortiz-Conde, B., Hollingshead, M., and Merlino, G. (2009). Lentivirus-mediated bifunctional cell labeling for in vivo melanoma study. Pigment Cell Melanoma Res. 22, 283-295.
11. Ebert, M.S., and Sharp, P.A. (2010). MicroRNA sponges: progress and possibilities. RNA 16, 2043-2050.
12. Garofalo, M., Romano, G., Di Leva, G. et al. (2012). EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nat. Med. 18, 74-82.
13. Gaziel-Sovran, A., Segura, M.F., Di Micco, R. et al. (2011). miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell 20, 104-118.
14. Gerald, J.N.F., Benjamin, J.M., and Kron, S.J. (2002). Robust G1 checkpoint arrest in budding yeast: dependence on DNA damage signaling and repair. J. Cell Sci. 115, 1749-1757.
15. Hanna, S.C., Krishnan, B., Bailey, S.T. et al. (2013). HIF1α and HIF2α independently activate SRC to promote melanoma metastases. J. Clin Invest. 123, 2078-2093.
16. Hemann, M.T., Fridman, J.S., Zilfou, J.T. et al. (2003). An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat. Genet. 33, 396-400.
17. Hill, V.K., Gartner, J.J., Samuels, Y., and Goldstein, A.M. (2013). The genetics of melanoma: recent advances. Annu. Rev. Genomics Hum. Genet. 14, 257-279.
18. Hoek, K.S., and Goding, C.R. (2010). Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell Melanoma Res. 23, 746-759.
19. Hoek, K.S., Schlegel, N.C., Brafford, P. et al. (2006). Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res. 19, 290-302.
20. Huang, X., Le, Q.-T., and Giaccia, A.J. (2010). MiR-210-micromanager of the hypoxia pathway. Trends Mol. Med. 16, 230-237.
21. Hwang, H.-W., Wentzel, E.A., and Mendell, J.T. (2009). Cell-cell contact globally activates microRNA biogenesis. Proc. Natl Acad. Sci. 106, 7016-7021.
22. Jeffs, A.R., Glover, A.C., Slobbe, L.J. et al. (2009). A gene expression signature of invasive potential in metastatic melanoma cells. PLoS ONE 4, e8461.
23. Kasinski, A.L., and Slack, F.J. (2011). Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat. Rev. Cancer 11, 849-864.
24. Kelly, T.J., Souza, A.L., Clish, C.B., and Puigserver, P. (2011). A hypoxia-induced positive feedback loop promotes hypoxia-inducible factor 1 alpha stability through miR-210 suppression of glycerol-3-phosphate dehydrogenase 1-like. Mol. Cell. Biol. 31, 2696-2706.
25. Kim, V.N., Han, J., and Siomi, M.C. (2009). Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 10, 126-139.
26. Kulshreshtha, R., Ferracin, M., Wojcik, S.E. et al. (2007). A microRNA signature of hypoxia. Mol. Cell. Biol. 27, 1859-1867.
27. Lanni, J.S., and Jacks, T. (1998). Characterization of the p53-dependent postmitotic checkpoint following spindle disruption. Mol. Cell. Biol. 18, 1055-1064.
28. Levy, C., Khaled, M., Robinson, K.C. et al. (2010). Lineage-specific transcriptional regulation of DICER by MITF in melanocytes. Cell 141, 994-1005.
29. Liao, W.-X., Laurent, L.C., Agent, S., Hodges, J., and Chen, D.-B. (2012). Human placental expression of SLIT/ROBO signaling cues: effects of preeclampsia and hypoxia. Biol. Reprod. 86, 111.
30. Lu, J., Getz, G., Miska, E.A. et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435, 834-838.
31. Lujambio, A., and Lowe, S.W. (2012). The microcosmos of cancer. Nature 482, 347-355.
32. Majmundar, A.J., Wong, W.J., and Simon, M.C. (2010). Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 40, 294-309.
33. Mellor, H.R., and Harris, A.L. (2007). The role of the hypoxia-inducible BH3-only proteins BNIP3 and BNIP3L in cancer. Cancer Metastasis Rev. 26, 553-566.
34. Mendell, J.T., and Olson, E.N. (2012). MicroRNAs in stress signaling and human disease. Cell 148, 1172-1187.
35. Nikolaou, V., and Stratigos, A.J. (2014). Emerging trends in the epidemiology of melanoma. Br. J. Dermatol. 170, 11-19.
36. Pencheva, N., and Tavazoie, S.F. (2013). Control of metastatic progression by microRNA regulatory networks. Nat. Cell Biol. 15, 546-554.
37. Pencheva, N., Tran, H., Buss, C., Huh, D., Drobnjak, M., Busam, K., and Tavazoie, S.F. (2012). Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell 151, 1068-1082.
38. Selbach, M., Schwanhäusser, B., Thierfelder, N., Fang, Z., Khanin, R., and Rajewsky, N. (2008). Widespread changes in protein synthesis induced by microRNAs. Nature 455, 58-63.
39. Sheehy, N.T., Cordes, K.R., White, M.P., Ivey, K.N., and Srivastava, D. (2010). The neural crest-enriched microRNA miR-452 regulates epithelial-mesenchymal signaling in the first pharyngeal arch. Development. 137, 4307-4316.
40. Siegel, R., Naishadham, D., and Jemal, A. (2013). Cancer statistics, 2013. CA Cancer J. Clin. 63, 11-30.
41. Sullivan, R., and Graham, C.H. (2007). Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev. 26, 319-331.
42. Thompson, M.R., Xu, D., and Williams, B.R.G. (2009). ATF3 transcription factor and its emerging roles in immunity and cancer. J. Mol. Med. 87, 1053-1060.
43. Westbroek, W., Klar, A., Cullinane, A.R. et al. (2012). Cellular and clinical report of new Griscelli syndrome type III cases. Pigment Cell Melanoma Res. 25, 47-56.
44. Widmer, D.S., Hoek, K.S., Cheng, P.F., Eichhoff, O.M., Biedermann, T., Raaijmakers, M.I.G., Hemmi, S., Dummer, R., and Levesque, M. (2013). Hypoxia Contributes to Melanoma Heterogeneity by Triggering HIF1α-Dependent Phenotype Switching. J. Invest. Dermatol. 133, 2436-2443.